Chemoinformaics analysis of 1-Phenylbutane-1,4-diol
| Molecular Weight | 166.22 | nRot | 4 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 166.099 | nRing | 1 |
| Solubility: LogS | -0.808 | nHRing | 0 |
| Solubility: LogP | 0.867 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 2 | BPOL | 14.0449 |
| QED | 0.711 |
| Synth | 2.147 |
| Natural Product Likeliness | 0.7 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.006 |
| HIA | 0.444 |
| CACO-2 | -4.485 |
| MDCK | 0.0000237 |
| BBB | 0.46 |
| PPB | 0.241718 |
| VDSS | 2.085 |
| FU | 0.665859 |
| CYP1A2-inh | 0.103 |
| CYP1A2-sub | 0.39 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.119 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.155 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.187 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.427 |
| CL | 9.005 |
| T12 | 0.709 |
| hERG | 0.039 |
| Ames | 0.013 |
| ROA | 0.039 |
| SkinSen | 0.473 |
| Carcinogencity | 0.043 |
| EI | 0.976 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.893554 |